catechin has been researched along with thromboplastin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schrör, K; Stampfuss, JJ; Weber, AA | 1 |
| Bae, JY; Hyon, SH; Kurihara, M; Matsumura, K; Takayama, H; Tsutsumi, S | 1 |
| Huang, H; Lo, WY; Lu, TL; Wang, HJ | 1 |
| Liu, J; Mu, Y; Wang, T; Xie, H; Xu, Y; Zhang, X; Zhou, H | 1 |
4 other study(ies) available for catechin and thromboplastin
| Article | Year |
|---|---|
Green tea catechins containing a galloyl group in the 3' position inhibit tissue factor-induced thrombin generation.
Topics: Blood Platelets; Catechin; Humans; In Vitro Techniques; Molecular Structure; Tea; Thrombin; Thromboplastin | 2005 |
Preservation of platelets by adding epigallocatechin-3-o-gallate to platelet concentrates.
Topics: Antioxidants; Apoptosis; Blood Platelets; Blood Preservation; Caspase 3; Catechin; Chemokine CCL5; Gelsolin; Humans; L-Lactate Dehydrogenase; P-Selectin; Thromboplastin | 2009 |
(-)-Epigallocatechin-3-gallate decreases thrombin/paclitaxel-induced endothelial tissue factor expression via the inhibition of c-Jun terminal NH2 kinase phosphorylation.
Topics: Anthracenes; Catechin; Cells, Cultured; Drug-Eluting Stents; Endothelium, Vascular; Humans; JNK Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Thrombin; Thromboplastin; Transcription Factor RelA | 2010 |
Epigallocatechin-3-gallate inhibits TF and TNF-α expression induced by the anti-β2GPI/β2GPI complex in human THP-1 cells.
Topics: Antibodies; beta 2-Glycoprotein I; Catechin; Cell Line; Enzyme Activation; Humans; MAP Kinase Signaling System; NF-kappa B; RNA, Messenger; Thromboplastin; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |